CM
INBX icon

Cigogne Management’s Inhibrx INBX Stock Holding History

Cigogne Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$1.17M Buy
+75,932
New +$1.16M 0.69% 49

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
SC
Slotnik Capital Dallas, Texas $342M AUM 105.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cigogne Management's INBX Position: Q4 2024 in Review

Cigogne Management opened a new position in Inhibrx (INBX) in Q4 2024: 75,932 shares worth $1.17M. The stake represents 0.69% of the portfolio and ranks #49 among its holdings.

101 funds tracked by Wall St. Rank hold INBX as of Q4 2024.

  • Cigogne Management held 75,932 shares of Inhibrx worth $1.17M as of Q4 2024.
  • Inhibrx was a new Cigogne Management position in Q4 2024.
  • Inhibrx made up 0.69% of Cigogne Management's portfolio in Q4 2024, its #49 holding.
  • 101 funds tracked by Wall St. Rank held Inhibrx as of Q4 2024.

Based on Cigogne Management's 13F filing for Q4 2024, filed 14 Feb 2025.